Implementation Lead Task (IL task provided by CCNSW) | Scheduled | Actual | Approach to Achieving Task (i.e. method of contact, number of staff approached) | Time Spent (mins) | Implementation Lead Reflection (i.e. barriers and facilitators, delays/setbacks, strategies used to address issues) | Outcome | ||
---|---|---|---|---|---|---|---|---|
Begin [date] | End [date] | Begin [date] | End [date] | |||||
Example: Recruit an implementation team of 8-12 health professionals involved in the LS pathway | 01/08/18 | 14/08/18 | 01/08/18 | 18/08/18 | 01/08/18: Hospital Principal Investigator emailed invitation letter to 28 staff members involved in LS pathway. 12 expressions of interest received. | 30 | – Poor attendance at initial Study Brief meeting. Second meeting held, offered to meet with staff individually if unable to attend group study brief meetings. | Implementation Team successfully formed, consisting of 8 health professionals: |
02/08/18: Emailed interested staff members (n=12) invitation to attend study brief meeting. 8 confirmed attendance. | 30 | – At study brief meeting, staff overall positive but raised concerns about time taken to attend meetings/focus groups held as part of LS implementation approach. Concerned thqt managers would not support. Advised that study has been granted executive approval, offered to arrange meeting with managers to discuss time/resources required for involvement as implementation team member | surgeons=2, oncologist=1, pathologists=2, | |||||
09/08/18: Held study brief meeting, 6 attended (2x surgeons, 1x medical oncologist, 1x pathologist, 1x genetic counsellor, 1x nurse coordinator). Info packs provided. | 90 | – Deadline for return of consent forms extended as second study brief meeting was required. | clinical nurse coordinator=1 | |||||
10/08/18: Non-attendees (n=6) invited to additional study brief meeting | 20 | genetic counsellor=1, oncology registrar=1 | ||||||
12/08/18: Second study brief meeting held, 4 attendees. Info packs provided (1x medical oncologist, 1x surgeon, 1x oncology registrar, 1x nurse) | 90 | |||||||
14/08/18: 5 participation consent forms received. Sent email reminder to remaining staff (n=7). Deadline extended to 18/08/18 – 3 additional consent forms returned. | 20 |